COMPARATIVE EVALUATION OF ACUTE TOXICITY AND PHARMACOLOGICAL ACTIVITY OF THE “ZUMAGRAST” PREPARATION IN COMPARISON WITH THE REFERENCE DRUG “ZARSIO®”
Keywords:
Zumagrast, Zarsio®, granulocyte colony‑stimulating factor, acute toxicity, leukocytosis, biological equivalence.Abstract
The development of locally manufactured biopharmaceuticals in the Republic of Uzbekistan requires comprehensive preclinical evaluation of their safety, pharmacological activity, and therapeutic equivalence to internationally recognized reference products. Granulocyte colony‑stimulating factor (G‑CSF) preparations play a pivotal role in the prevention and treatment of neutropenia associated with cytotoxic chemotherapy, radiation exposure, and various immunopathological conditions.References
1. Belenky ML. Elements of Quantitative Evaluation of Pharmacological Effects. Leningrad; 1963. pp. 81–90.
2. Burbello AT, Shabrov AV. Modern Medicines. Moscow; 2007. 800 p.
3. Guskova TA. Toxicology of Medicinal Products. Moscow; 2008. pp. 27–30.
4. Matitsina AP. Pathophysiology of White Blood Cells. Blagoveshchensk; 2012. pp.5-6
5. Khabriev RU, editor. Guidelines for Experimental (Preclinical) Study of New Pharmacological Substances. Moscow: Meditsina; 2005. pp. 41–54.
6. Khabriev RU, editor. Statistical Methods in Pharmacological Experiments. Moscow: Meditsina; 2005. pp. 763–774.
7. Stefanov AV. Preclinical Studies of Medicinal Products. Kyiv; 2002. p. 91.
Downloads
Published
2025-12-29
Issue
Section
Articles
How to Cite
[1]
2025. COMPARATIVE EVALUATION OF ACUTE TOXICITY AND PHARMACOLOGICAL ACTIVITY OF THE “ZUMAGRAST” PREPARATION IN COMPARISON WITH THE REFERENCE DRUG “ZARSIO®”. Ustozlar uchun. 86, 6 (Dec. 2025), 118–122.
